Female CEOs
Health
Pharmaceutical

Editas Medicine

9,846

$22.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.20 (+0.88%) Today
$0.00 (0.00%) As of 6:18 PM EST after-hours

Why Robinhood?

You can buy or sell EDIT and other stocks, options, ETFs, and crypto commission-free!

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR); and CRISPR associated protein 9 (Cas9). Read More The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA.

CEO
Cynthia L. Collins
Employees
133
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
1.13B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
629.10K
High Today
$23.29
Low Today
$22.64
Open Price
$22.82
Volume
460.08K
52 Week High
$32.46
52 Week Low
$17.80

Collections

Female CEOs
Health
Pharmaceutical
Therapy
Medical
Technology
Biotechnology
2016 IPO

EDIT News

ReutersNov 12

Edited Transcript of EDIT earnings conference call or presentation 12-Nov-19 1:00pm GMT

Q3 2019 Editas Medicine Inc Earnings Call Cambridge Nov 12, 2019 (Thomson StreetEvents) -- Edited Transcript of Editas Medicine Inc earnings conference call or
10

EDIT Earnings

-$0.82
-$0.65
-$0.49
-$0.32
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
-$0.66 per share
Replay Earnings Call

You May Also Like

PILL
SLGN
CRBP
SOL
SITC
TXMD
JETS
PNR
RMG+
JAGG
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy EDIT

Market Price$22.86
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell EDIT stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up